Organ/Tissue/Blood Donation
May 11, 2023
The Food and Drug Administration May 11 finalized revised recommendations for assessing blood donor eligibility, which use the same risk-based questions for every donor regardless of sexual orientation, sex or gender.
Mar 29, 2023
AHA today applauded and urged the Food and Drug Administration to finalize its draft guidance proposing that blood donor eligibility be determined based on individual risk assessment, regardless of gender or sexual orientation.
Mar 29, 2023
AHA comments on the FDA's draft guidance proposing that blood donor eligibility be determined based on individual risk assessment, regardless of gender or sexual orientation.
Jan 31, 2023
The Food and Drug Administration (FDA) Jan. 27 issued draft guidance proposing a shift in federal policy on who may donate blood. The policy would eliminate the existing time-based blood donation deferrals for men who have sex with men (MSM) and women who have sex with MSM.
Jan 27, 2023
The FDA is signaling a major shift in federal policy on who may donate blood, proposing guidelines that would eliminate the existing time-based blood donation deferrals for men who have sex with men and women who have sex with those individuals.
Oct 17, 2022
The international division of America’s Blood Centers recently launched a website to connect blood donors with donation sites. The site also includes donor stories and educational resources on blood donation for teachers and the media.
Aug 5, 2022
HHS launched Giving = Living, a campaign to encourage Americans to donate blood and plasma regularly.
Mar 21, 2022
Americas Blood Centers Friday released a bulletin on blood shortages and how hospitals and their clinicians can help.
Mar 7, 2022
A shortage of BioFlex blood bags made by Fresenius Kabi is impacting an estimated 10%-15% of whole blood collections, America’s Blood Centers and Blood Centers of America reported.
Feb 28, 2022
A new report from the National Academies of Sciences, Engineering, and Medicine recommends changes to improve fairness, equity, transparency and cost-effectiveness in the U.S. organ transplant system.